Real-World Evaluation of Disparities in Prostate Cancer Outcomes - Daniel Spratt

May 31, 2019

Daniel Spratt and Todd Morgan discuss the analysis of why is it that black men appear to be dying more often of prostate cancer.  They review their approach to understanding more about this real-world question.


Todd Matthew Morgan MD Associate Professor Specialties: Urology Area of Practice: Prostate Cancer, including robotic prostatectomy and active surveillance; Bladder Cancer, including bladder preservation approaches as well as open and robotic radical cystectomy; Kidney Cancer, including open and robotic approaches, and nephron-sparing (i.e. partial nephrectomy) when appropriate; and Penile Cancer, including robotic inguinal lymphadenectomy. Michigan Medicine Urology Oncology Clinic | Rogel Cancer Center

Daniel Spratt, MD Associate Professor Laurie Snow Research Professor of Radiation Oncology Associate Chair, Clinical Research Chair, Genitourinary Clinical Research, Rogel Cancer Center Director, Spine Oncology Program, Rogel Cancer Center

Charles J. Ryan, MD, B.J. Kennedy Chair in Clinical Medical Oncology at the University of Minnesota and Director of the Division of Hematology, Oncology, and Transplantation. He previously held the position of Professor of Clinical Medicine and Urology and the Clinical Program Leader for Genitourinary Medical Oncology at the UCSF Helen Diller Family Comprehensive Cancer Center